Cargando…

Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies

Risperidone is one of the most commonly used antipsychotics (AP), due to its safety and efficacy in reducing psychotic symptoms. Despite the favorable side effect profile, the therapy is accompanied by side effects due to the non-selectivity of this medicine. This review will briefly highlight the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stojkovic, Milena, Radmanovic, Branimir, Jovanovic, Mirjana, Janjic, Vladimir, Muric, Nemanja, Ristic, Dragana Ignjatovic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121093/ https://www.ncbi.nlm.nih.gov/pubmed/35599770 http://dx.doi.org/10.3389/fpsyt.2022.874705

Ejemplares similares

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia
por: Lin, Chih-Hsun, et al.
Publicado: (2012)

Management of risperidone-induced hyperprolactinemia in children: a case report
por: Belhadga, H., et al.
Publicado: (2023)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
por: Muric, Nemanja N., et al.
Publicado: (2020)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Risperidone-Induced Sexual Dysfunction Case Report
por: Cichon, Gregory J, et al.
Publicado: (2023)

The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
por: Park, Eun Jin, et al.
Publicado: (2015)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Pathophysiology and management of risperidone-induced sialorrhea: case report
por: Torrico, Tyler, et al.
Publicado: (2023)

Clozapine prescription rates in Southeast Europe: A cross-sectional study
por: Russo, Manuela, et al.
Publicado: (2023)

Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
por: Fu, Yun, et al.
Publicado: (2022)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature
por: Najmi, Ahmad, et al.
Publicado: (2020)

Correlation of Clinicopathological Characteristics of Breast Carcinoma and Depression
por: Ilic, Milena B, et al.
Publicado: (2019)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
por: Gianfrancesco, Frank D, et al.
Publicado: (2009)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

Schizoaffective Disorder That Is Induced By Electrical Voltage That Is Treated with Risperidone
por: Fadhilah, Ihsan, et al.
Publicado: (2019)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Association Study of KCNH7 Polymorphisms and Individual Responses to Risperidone Treatment in Schizophrenia
por: Wang, Xueping, et al.
Publicado: (2019)

The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review
por: Hutchinson, Jhenelle, et al.
Publicado: (2023)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Factors Influencing The Six-Month Mortality Rate In Patients With A Hip Fracture
por: Prodovic, Tanja, et al.
Publicado: (2016)

Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial
por: Latrèche, Caren, et al.
Publicado: (2022)

Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach
por: Levine, Samara, et al.
Publicado: (2018)

Regulatory Issues Surrounding Audit of Electronic Cigarette Charge Composition
por: Jovanovic, Mirjana, et al.
Publicado: (2015)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study
por: Ignjatovic-Ristic, Dragana, et al.
Publicado: (2013)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model
por: Li, Guangfei, et al.
Publicado: (2020)

Histone deacetylase inhibitors mitigate antipsychotic risperidone-induced motor side effects in aged mice and in a mouse model of Alzheimer’s disease
por: Rodriguez, Guadalupe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_op8p5o2bqob22rje63fs695dk6